| Name | (2S,3aS,7aS)-1-[(2S)-2-[[(1S)-1-carboxybutyl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid |
|---|---|
| Synonyms |
(2S-(1(R*(R*)),2a,3ab,7ab))-Octahydro-1-(2-((1-carboxybutyl)amino)-1-oxopropyl)-1H-indole-2-carboxylic Acid
(2S,3aS,7aS)-1-((S)-N-((S)-1-Carboxybutyl)alanyl)hexahydro-2-indolinecarboxylic acid Perindoprilat (2S,3aS,7aS)-1-[(2S)-2-[[(1S)-1-carboxybutyl]amino]-propanoyl]octahydro-1H-indole-2-carboxylic acid (2S,3aS,7aS)-1-[(2S)-2-{[(1S)-1-Carboxybutyl]amino}propanoyl]octahydro-1H-indole-2-carboxylic acid S-9780 Perindoprilato [Spanish] Perindoprilate [French] UNII-2UV6ZNQ92K Perindoprilatum [Latin] |
| Description | Perindoprilat (S 9780) is an angiotensin-converting enzyme (ACE) inhibitor with the IC50 value ranging from 1.5 to 3.2 nM. Perindoprilat can be used in hypertension research[1][2]. |
|---|---|
| Related Catalog | |
| In Vitro | Perindoprilat (1 μM, 10 days) treatment suppresses the angiotensin II production in HNSCC cells[3]. Cell Viability Assay[3] Cell Line: HNSCC cells Concentration: 1 μM Incubation Time: 10 days Result: Suppressed the angiotensin II production in HNSCC cells (P=0.028). |
| References |
[1]. Perindopril. Expert Opin Pharmacother. 2006 Jan;7(1):63-71. |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 568.1±45.0 °C at 760 mmHg |
| Melting Point | 153-155ºC |
| Molecular Formula | C17H28N2O5 |
| Molecular Weight | 340.415 |
| Flash Point | 297.4±28.7 °C |
| Exact Mass | 340.199829 |
| PSA | 106.94000 |
| LogP | 2.37 |
| Vapour Pressure | 0.0±3.4 mmHg at 25°C |
| Index of Refraction | 1.535 |
| Storage condition | -20°C Freezer |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| RIDADR | NONH for all modes of transport |
|---|
|
~72%
95153-31-4 |
| Literature: Pascard; Guilhem; Vincent; Remond; Portevin; Laubie Journal of Medicinal Chemistry, 1991 , vol. 34, # 2 p. 663 - 669 |
|
~0%
95153-31-4 |
| Literature: WO2007/58634 A1, ; Page/Page column 17-19 ; |
| Precursor 1 | |
|---|---|
| DownStream 0 | |